Quest Diagnostics Pay $1.79 Million To Settle False Claims Act Allegations
Last week, the Justice Department announced that Quest Diagnostics Inc. and Quest Diagnostics Clinical Laboratories…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Hospital Compare Survey Of Patient Experience: Highest Scores For Small,…
Earlier this year, the Centers for Medicare and Medicaid Services (CMS) added a new star rating system to its Hospital…
EHR: Congress Moves to Delay and Modify Timeline for Meaningful Use
There is a growing movement in Congress to push the Department of Health and Human Services (HHS) to postpone Stage 3 of the…
Be Careful What You Wish For? FDA’s Biosimilars Naming Guidance Proposes…
Yesterday, the Food and Drug Administration (FDA) released much anticipated guidance on how they plan to address nonproprietary…
FTC Urges FDA To Reevaluate Current Approach To Regulating Homeopathic…
Last week, the Federal Trade Commission (FTC) recommended that the Food and Drug Administration (FDA) consider…
New Report Looks At Intersection of “Medical Lending” and…
A recent article in Reuters shed an interesting and potentially disturbing light on the “medical lending” industry,…
UK Health Secretary Announces Mandatory “Sunshine Rule” After…
Yesterday, British Health Secretary Jeremy Hunt announced that all National Health Service hospitals and General…
Purdue Pharma Settles With New York AG Over Oxycontin Promotion; Agrees To…
New York’s Attorney General recently announced an agreement with Purdue Pharma, the manufacturer of OxyContin, that…
CMS Proposed Fee Schedule for 2016 Overview
As we previously published, on July 15, 2015, the Centers for Medicare & Medicaid Services (CMS) published its proposed rule…
Amgen Pays $71 Million to States For Off-Label Allegations In Violation of…
Earlier this week, Amgen Inc. agreed to pay $71 million to 48 states to settle allegations that it violated state consumer…